TC Web Desk
In a new development, the first Indian monkeypox has been reported in Kerala. The patient travelled from UAE and reached the state on 12 July. Kerala Health Minister Veena George said that “all measures are being taken as per the guidelines issued by WHO and ICMR”.
According to the Health Ministry, the patient’s condition is quite stable and all the majors are normal. “The primary contacts are identified – his father, mother, taxi driver, auto driver, and 11 passengers of the same flight who were in adjacent seats,” it said as quoted by ANI.
Meanwhile, the Center said it would deploy a multi-disciplinary core team to help the Kerala government investigate the outbreak and initiate necessary health measures.
“In view of the report of confirmation of a case of Monkeypox disease from Kollam district, Kerala, it has been decided to depute the following multi-disciplinary Central Team to support State Government of Kerala in investigating the outbreak and institute requisite public health measures” an official statement read.
The World Health Organization (WHO) has announced that it will hold an emergency meeting next week to assess whether monkeypox should be declared a global emergency. Last month, the agency said it had yet to confirm the outbreak, but said it would infect more vulnerable populations such as children with monkeypox and considered issues such as whether the virus was causing more severe disease.
Monkeypox is a rare viral infection that rarely spreads to humans. The UK Health Security Agency (UKHSA) said: “it is usually a mild self-limiting illness and most people recover within a few weeks. However, severe illness can occur in some individuals.”
Some common symptoms include muscle aches, back pain, headache, swollen lymph nodes, chills and fatigue.
The initial stage of the disease lasts about 5 days “Patients may experience a combination of fever and/or chills, lymphadenopathy, headache, myalgia, back pain and fatigue. Fever occurs in most, but not all, patients. ,
In the second stage, a rash appears. According to WHO, in 95% of cases, it is believed to be concentrated on the face.
